REQUEST A DEMO
Total
USD $0.00
Search more companies

Eversana Poland Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Eversana Poland Sp. z o.o. Profile Updated: October 09, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Eversana Poland Sp. z o.o. is based in Poland. The head office is in Warsaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. It was incorporated on September 25, 2019. From the latest financial highlights, Eversana Poland Sp. z o.o. reported a net sales revenue increase of 39.59% in 2024. Its’ total assets recorded a growth of 32.53%. In, 2024, the company’s net profit margin increased by 0.27%.

Headquarters
Ul. Wronia 10
Warsaw; Mazowieckie; Postal Code: 00-840

Contact Details: Purchase the Eversana Poland Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Eversana Poland Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Eversana Poland Sp. z o.o. report to view the information.
Incorporation Date:
September 25, 2019
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Eversana Poland Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
39.59%
Total operating revenue
39.59%
Operating profit (EBIT)
38.35%
EBITDA
38.35%
Net Profit (Loss) for the Period
44.55%
Total assets
32.53%
Total equity
63.53%
Operating Profit Margin (ROS)
-0.08%
Net Profit Margin
0.27%
Return on Equity (ROE)
-5.1%
Quick Ratio
0.76%
Cash Ratio
0.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?